Reports of COVID-19-associated mucormycosis have been increasing in frequency since
early 2021, particularly among patients with uncontrolled diabetes. Patients with diabetes …

Mucormycosis is an angioinvasive fungal infection, due to fungi of the order Mucorales. Its
incidence cannot be measured exactly, since there are few population-based studies, but …

Abstract The coronavirus disease 2019 (COVID-19) pandemic has led to a concerning
resurgence of mucormycosis. More than 47,000 cases of mucormycosis were reported in …

Abstract Purpose of Review Infectious diseases represent up to 12% of all deaths in people
with diabetes mellitus (DM). The development and progression of DM generate a chronic …

Mucormycosis (MCR) is an emerging and frequently lethal fungal infection caused by the
Mucorales family, with Rhizopus, Mucor, and Lichtheimia, accounting for> 90% of all cases …

Patients with respiratory viral infections are more likely to develop co-infections leading to
increased fatality. Mucormycosis is an epidemic amidst the COVID-19 pandemic that …

RNA interference (RNAi) was discovered at the end of last millennium, changing the way
scientists understood regulation of gene expression. Within the following two decades, a …

The classification of Mucorales encompasses a collection of basal fungi that have
traditionally demonstrated an aversion to modern genetic manipulation techniques. This …

Combatting the ever-increasing threat from invasive fungal pathogens faces numerous
fundamental challenges, including constant human exposure to large reservoirs of species …

Mucormycosis is a lethal and emerging disease that has lacked a genetic model fulfilling
both high virulence and the possibility of performing stable and reproducible gene …